Article
[Assessment of the presence of mutations of the epidermal growth factor receptors in tumors of various histologies].
I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] - 1 Jan 2000
Leone A, Pisa R, Gasbarra R, Costanzi-Porrini S, Cavazzana A, Bevilacqua G, Graziano P, Remotti D, Valle M, Garofalo A
Abstract excerpt
Recent reports from US and Japan have established that mutations in the tyrosine kinase (TK) domain of the epidermal growth factor receptor (Egfr) occur in a subset of patients with lung cancer that respond to therapy with gefitinib, a TK inhibitor. To gain further insights into the role of Egfr in carcinogenesis of lung and tumors of diverse histology, that are currently under investigation with drugs of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
